Effects of proton pump inhibitor on gastroesophageal varices in patients with cirrhosis: A randomized controlled trial from China

[1]  Xianglong Zheng,et al.  Adverse outcomes of proton pump inhibitors in chronic liver disease: a systematic review and meta-analysis , 2020, Hepatology International.

[2]  Y. Chan,et al.  Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis , 2019, World journal of gastroenterology.

[3]  P. Andersen,et al.  Effect of proton pump inhibitors on the risk and prognosis of infections in patients with cirrhosis and ascites , 2019, Liver international : official journal of the International Association for the Study of the Liver.

[4]  S. Saligram,et al.  Update on the management of gastrointestinal varices , 2019, World journal of gastrointestinal pharmacology and therapeutics.

[5]  A. Farcomeni,et al.  Proton Pump Inhibitors Are Associated With Minimal and Overt Hepatic Encephalopathy and Increased Mortality in Patients With Cirrhosis , 2018, Hepatology.

[6]  A. Waness,et al.  Increased Risk of Spontaneous Bacterial Peritonitis in Cirrhotic Patients Using Proton Pump Inhibitors , 2018, GE - Portuguese Journal of Gastroenterology.

[7]  F. Chan,et al.  Asia-Pacific working group consensus on non-variceal upper gastrointestinal bleeding: an update 2018 , 2018, Gut.

[8]  E. Yoshida,et al.  Association of proton pump inhibitors with the risk of hepatic encephalopathy during hospitalization for liver cirrhosis , 2018, United European gastroenterology journal.

[9]  X. Qi,et al.  Acid suppression in patients treated with endoscopic therapy for the management of gastroesophageal varices: a systematic review and meta-analysis , 2018, Expert review of gastroenterology & hepatology.

[10]  R. Chung,et al.  Proton pump inhibitors are associated with accelerated development of cirrhosis, hepatic decompensation and hepatocellular carcinoma in noncirrhotic patients with chronic hepatitis C infection: results from ERCHIVES , 2018, Alimentary pharmacology & therapeutics.

[11]  Y. Seo.  Prevention and management of gastroesophageal varices , 2017, Clinical and molecular hepatology.

[12]  Deng-Chyang Wu,et al.  The Role of Adjuvant Acid Suppression on the Outcomes of Bleeding Esophageal Varices after Endoscopic Variceal Ligation , 2017, PloS one.

[13]  J. Bosch,et al.  Prevention and treatment of variceal haemorrhage in 2017 , 2017, Liver international : official journal of the International Association for the Study of the Liver.

[14]  J. Bosch,et al.  Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases , 2017, Hepatology.

[15]  J. Hyun,et al.  Proton Pump Inhibitor Therapy Is Associated With Reduction of Early Bleeding Risk After Prophylactic Endoscopic Variceal Band Ligation , 2016, Medicine.

[16]  J. Bosch,et al.  Varices and Variceal Hemorrhage in Cirrhosis: A New View of an Old Problem. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[17]  J. Cha,et al.  Proton pump inhibitor administration delays rebleeding after endoscopic gastric variceal obturation. , 2014, World journal of gastroenterology.

[18]  C. Tai,et al.  Controlled trial of ligation plus vasoconstrictor versus proton pump inhibitor in the control of acute esophageal variceal bleeding , 2013, Journal of gastroenterology and hepatology.

[19]  S. Tanabe,et al.  Long-term administration of PPI reduces treatment failures after esophageal variceal band ligation: a randomized, controlled trial , 2012, Journal of Gastroenterology.

[20]  N. Chavez-Tapia,et al.  PPIs are not associated with a lower incidence of portal-hypertension-related bleeding in cirrhosis. , 2010, World journal of gastroenterology.

[21]  L. Welage,et al.  Continuous Infusion of Pantoprazole with Octreotide Does Not Improve Management of Variceal Hemorrhage , 2009, Pharmacotherapy.

[22]  N. Shaheen,et al.  Pantoprazole reduces the size of postbanding ulcers after variceal band ligation: A randomized, controlled trial , 2005, Hepatology.

[23]  P. Hayes,et al.  UK guidelines on the management of variceal haemorrhage in cirrhotic patients , 2000, Gut.

[24]  S. Sarin,et al.  Prevalence, classification and natural history of gastric varices: A long‐term follow‐up study in 568 portal hypertension patients , 1992, Hepatology.

[25]  M. Djaldetti,et al.  The effect of pH on platelet and coagulation factor activities. , 1978, American journal of surgery.

[26]  [Guidelines for the diagnosis and treatment of acute non-variceal upper gastrointestinal bleeding (2018, Hangzhou)]. , 2019, Zhonghua nei ke za zhi.

[27]  R. de Franchis.  Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. , 2015, Journal of hepatology.

[28]  E. Ancona,et al.  Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. , 1988, The New England journal of medicine.